About us

A new modality to
revolutionize the treatment of
immunological diseases.

LoopLab is a team of biotech enthusiasts committed to creating a novel therapeutic modality to revolutionize the way specific diseases are treated. Building on vast knowledge and experience in the field of immunology, molecular biology and virology, LoopLab has built synthetic molecular machines (“SelfAmps”) to address particular cells and tissues to precisely alter their biology and enable a new way to treat disease.

Management Team

LoopLab is led by a visionary and experienced management team with proven track records in the biotech and pharmaceutical industry.

Erich Tauber


Erich is the Chief Executive Officer and Co-founder of LoopLab. He is an experienced biotech entrepreneur with over 20 years of experience in establishing and leading successful drug development companies. Previously, Erich was the CEO and co-founder of Themis Bioscience, leading the pioneering vaccine developer for over 13 years, until its acquisition by MSD. He has also served in various leadership roles at prominent industry companies such as AstraZeneca, Baxter, Intercell, and Nycomed. Notably, Erich has played an important role in the development and commercialization of numerous therapies and vaccines. His expertise in vaccine and product development is well-recognized, and he has authored several scientific publications that contribute significantly to the field. Erich holds a Medical Doctorate from the Medical University in Vienna and was a paediatric research fellow at the Vienna University Children's Hospital and the Southampton Children's Hospital in the United Kingdom.

Jochen Stritzker


Jochen is the Chief Scientific Officer (CSO) and Co-founder of LoopLab. With over 20 years of experience in industrial and academic research, his expertise is focused on cancer immunotherapy, infectious diseases, molecular imaging, biomarkers, and translational research. Throughout his career, Jochen has held senior research roles, including Senior Principal Scientist at MSD, where he led the oncolytic virus and vaccine programs. He joined MSD following the acquisition of Themis Bioscience where he was Senior Vice President Immunotherapy. Prior to Themis, Jochen worked at Genelux in positions of increasing responsibility including Associate VP of Research where he was responsible for the company’s cancer immunotherapy research as well as strategic partnerships. Jochen holds a PhD in Biology from the Julius Maximilians University of Würzburg.

Roland Tschismarov


Roland is the Head of Translational Research and Co-founder of LoopLab. Roland's industry experience includes positions as a Principal Scientist in Biology Discovery at MSD. Prior to this, he was a Senior Clinical Scientist at Themis Bioscience. Before moving into the biotechnology industry, Roland was a Postdoctoral Scientist at the Max F. Perutz Laboratories of the University of Vienna and the Medical University of Vienna, where he made significant contributions to the field of inflammation and immunity. Roland holds a PhD in inflammation and immunity research from the Medical University of Vienna, and a Master of Science in Genetics and Biotechnology from Paris Lodron University Salzburg.

Simona Neubauer


Simona is the Head of Operations and Co-founder of LoopLab bringing over 15 years of operational expertise in the Pharma and Biotech sectors to LoopLab. Previously, Simona worked as Head of Quality Assurance and Associate Director of Quality Assurance at Themis Bioscience. She also served as a Quality Assurance Manager at Alcon and as Qualified Person at Kwizda Pharmadistribution. Simona started her career as a Monitoring Coordinator in Aseptic Processing department at Baxter BioScience. She holds a Magister's degree in Biology from Paris Lodron University Salzburg and an MBA.